Caplin Point Laboratories Schedules Q2 & H1 FY27 Earnings Call
Caplin Point Laboratories Ltd 路 Intimation 路 12 Nov 2026, 4:30 pm
Caplin Point Laboratories Schedules Q2 & H1 FY27 Earnings Call Caplin Point Laboratories will host its post-results earnings conference call on 12th Nov'26 at 16:30 IST to discuss its financial performance and business outlook for Q2 and H1 ended 30th Sep'26. Senior leadership, including Chairman C.C. Paarthipan, Managing Director Dr. Sridhar Ganesan, and CFO D. Muralidharan, will represent the company. Universal dial-in lines are available at +91 22 6280 1222 and +91 22 7115 8123, along with international toll-free access across key global regions.
Original exchange filing (PDF)
More announcements from Caplin Point Laboratories Ltd
- Classification of US FDA Inspection at the facility of Caplin Steriles Limited, subsidiary of the Company as OAI 路 17 Nov 2026
- Audio Recording of Earnings call for the Quarter and half year ended September 30, 2026 路 13 Nov 2026
- Investor Presentation for the Earnings Call for the Quarter and half year ended September 30, 2026 路 12 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 路 12 Nov 2026
- Board Meeting Outcome for Meeting Held on November 12, 2026 路 12 Nov 2026
- Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
- CAPLIN POINT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 12 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 12 Nov 2026
